Detalles de la búsqueda
1.
A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
J Immunol
; 212(12): 1922-1931, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683124
2.
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
J Virol
; 96(13): e0050922, 2022 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699447
3.
Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Platelets
; 34(1): 2157807, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636834
4.
Erratum for Lin et al., "Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity".
J Virol
; 97(2): e0008023, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749075
5.
Nurses best practices for the management of thrombotic thrombocytopenic purpura.
Transfus Apher Sci
; 57(3): 437-444, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29960714
6.
Illustrated treatment of refractory immune thrombotic thrombocytopenic purpura with caplacizumab.
BMJ Case Rep
; 14(8)2021 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373246
Resultados
1 -
6
de 6
1
Próxima >
>>